Pregnancy Structure/Function Claims Prompt Capitol Hill Attention
This article was originally published in The Tan Sheet
Executive Summary
FDA's reversal on structure/function claims for pregnancy-related conditions is likely to reinvigorate Capitol Hill debate over the agency's regulation of dietary supplements.
You may also be interested in...
Qualified Health Claims In “More Unified, Informative” Format Urged By CRN
The "good news, bad news" format FDA has adopted for qualified health claims seems "unlikely to provide consumers with a good understanding of the nature of the support that exists for the statement or the reasons for FDA's unfavorable view of the claim," according to the Council for Responsible Nutrition
Structure/Function Claim Nutritive Value Debate Reopened By FDA
FDA is seeking feedback on both its current regulatory approach to dietary supplement products bearing nutritive value-based structure/function claims and the potential impact of a policy reversal on the issue.
Fewer Structure/Function Claims Deemed Inappropriate By FDA In 1999
Cold, allergy and immune system claims were the most commonly cited statements in FDA "courtesy" letters issued to dietary supplement companies in 1999, although the number of letters addressing these conditions declined from 1998.